We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials PR Newswire NEW YORK, Feb. 4, 2021 NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Synaptogenix, Inc. (OTC: SNPX) announced...
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals - Petros to Grow and Pursue Non-Prescription / Over-The-Counter ("OTC") Strategies...
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with...
Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's Disease - Study Being Conducted in Collaboration with NIH Under a $2.7 Million Grant - PR...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.16 | -5.42372881356 | 2.95 | 3.1 | 2.79 | 3543 | 2.90999887 | CS |
| 4 | 0.14 | 5.28301886792 | 2.65 | 3.81 | 2.33 | 8615 | 2.91079139 | CS |
| 12 | 0.79 | 39.5 | 2 | 4.4 | 1.96 | 11818 | 2.92490641 | CS |
| 26 | -1.25 | -30.9405940594 | 4.04 | 4.72 | 1.475 | 10358 | 2.82441495 | CS |
| 52 | 1.849 | 196.493092455 | 0.941 | 6.8097 | 0.941 | 10188 | 3.83179727 | CS |
| 156 | 1.849 | 196.493092455 | 0.941 | 6.8097 | 0.941 | 3401 | 3.83179727 | CS |
| 260 | 1.97 | 240.243902439 | 0.82 | 6.8097 | 0.59 | 133152 | 1.2206891 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
